Accès à distance ? S'identifier sur le proxy UCLouvain
Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection.
Primary tabs
Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
---|---|
Publication date | 2004 |
Language | Anglais |
Conference | "55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)", Boston (Ma) (Oct 29-nov 02, 2004) |
Journal information | "Hepatology" - Vol. 40, no. 4, p. 282A-283A (2004) |
Peer reviewed | yes |
issn | 0270-9139 |
e-issn | 1527-3350 |
Publisher | John Wiley & Sons Inc (Hoboken) |
Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL |
Links |
Bibliographic reference | Horsmans, Yves ; Berg, T. ; Desager, Jean-Pierre ; Muller, T. ; Schott, E ; et. al. Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection..55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) (Boston (Ma), Oct 29-nov 02, 2004). In: Hepatology, Vol. 40, no. 4, p. 282A-283A (2004) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/61169 |